asrm_logo_color_tagline.png
Menu

Infertility

For more information on these press releases, contact: 

J. Benjamin Younger Office of Public Affairs
409 12th Street SW, Suite 602
Washington, DC 20024-2188
Tel: (202) 863-2494/Fax: (202) 484-4039 

Infertility Treatments Remained Strong With Good Outcomes In Spite Of Covid-19, According To Three Studies Presented At The ASRM 2021 Scientific Sessions

The COVID-19 pandemic disrupted many aspects of healthcare and caused a great deal of psychological stress among patients and temporary barriers to traditional care, leading to questions about the impact of the pandemic on fertility and assisted reproductive treatments. However, the results of three studies presented at ASRM’S 2021 Scientific Sessions show that with proper precautions, outcomes before and during the pandemic remained very similar in several aspects of infertility care – including egg retrieval and IVF cycles.

Even With Private Insurance Coverage, Black And Hispanic Women Are Less Likely To Receive Fertility Treatment

Historically, Black and Hispanic women have been less likely to receive fertility treatment compared to white women, and it was thought that lower income or a lack of insurance coverage may be the reason. However, results of a study presented at ASRM’s 2021 Scientific Congress indicate that even with private insurance coverage and women living in states that mandate coverage for fertility treatment, disparities exist.

Congress Renews Pledge to Achieve #IVF4All

Senator Cory Booker and Congresswoman and House Appropriations Committee Chairwoman Rosa DeLauro have re-introduced the Access to Infertility Care and Treatment Act, which requires certain insurers to provide coverage for infertility treatment, including fertility preservation services.

ASRM COVID-19 Task Force Issues Update No. 14

In the current update, the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to support both vaccination with currently available vaccines for all individuals, including women who are either pregnant or contemplating conception (see Update #11), and continued strict adherence to its earlier recommended mitigation strategies for disease prevention, including use of social distancing, and rigorous attention to hand washing, Personal Protective Equipment (PPE), especially masking, and quarantines when appropriate (see Update #3). In addition, the Task Force is issuing this update to assist reproductive care specialists in counseling their patients and their communities regarding vaccination, including vaccination in pregnancy, and to provide considerations for relaxing restrictions.

ASRM COVID-19 Task Force Releases Update #10 to Recommendations

The current update by the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to affirm the recommendations presented in Update No. 3 (American Society for Reproductive Medicine Patient Management and Clinical Recommendations during the Coronavirus (COVID-19) Pandemic - Update No. 3, April 24, 2020), which were further elaborated upon in Updates No. 4-9. Collectively, these updates recommend the judicious resumption of the delivery of reproductive care, with the use of careful preventive measures, such as the use of Personal Protective Equipment (PPE), including masks, frequent hand washing, and social distancing measures. Given the continued presence, and more recently the marked upsurge, of COVID-19 cases in much of the United States (U.S.), these strategies continue to be critical in managing this ongoing pandemic.

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew